- +971 50 312 9316
- info@menovivreclinic.com
- Mon-Fri: 8AM - 7PM | Sun: 8AM - 4PM
Menopause is a transition, not a disease.
But a transition of this magnitude, one that can affect your sleep, your thinking, your weight, your joints, your heart, your bones, your sexual health, and the way you feel in your own body, deserves more than being told it is a normal part of getting older.
At Menovivre, we take a different approach. Our aim is not simply to ask how we stop the hot flashes. It is to ask what this woman needs to feel well now and to support her long-term health in the years ahead.
Research published in The Lancet Global Health confirms that menopause is associated with several significant long-term health risks, including cardiovascular disease, the leading cause of death in women, making early, active management clinically important rather than optional. Read more on our blog about when to start thinking about menopause.
One of the most important messages for women is that menopause does not always look like the stereotypical picture of hot flashes and night sweats. The symptoms we see are incredibly diverse.
This is for you if:
A thorough menopause assessment starts with the woman, rather than the blood test.
We begin with a detailed history covering menstrual and reproductive history, symptoms, previous treatments, medications, family history, cardiovascular and metabolic risk, bone health, sexual and genitourinary health, sleep, nutrition, exercise, stress, and overall lifestyle.
We then decide what investigations are actually appropriate.
For many women, particularly those over 45 with a typical clinical presentation, menopause can be assessed based on the history and symptoms rather than relying on a single hormone level. Hormone levels fluctuate considerably during perimenopause, so a single blood test does not always reflect what is happening clinically.
Where indicated, blood testing may assess:
For women requiring a more detailed functional assessment, we may use specialised investigations where clinically appropriate, including more comprehensive metabolic, nutritional, gastrointestinal, or hormone-related assessments. We do not test for the sake of testing. Investigations are selected according to the clinical question and the individual patient.
What is different at Menovivre is the breadth of the assessment. We are interested not only in whether a woman is menopausal, but in why she is experiencing particular symptoms, what risks she may have, and what can be done to improve her health more broadly. Read more about our blood and hormone testing service and the article on what happens when blood tests are normal but you still feel unwell.
You Do Not Have to Navigate This Alone
A: Menopause is confirmed when twelve consecutive months have passed without a menstrual period. Perimenopause is the transitional phase before that, which can begin in the late thirties or early forties and may last several years. During perimenopause, hormone levels fluctuate, cycles become irregular, and many of the symptoms associated with menopause can begin. A detailed clinical history is often more informative than a single blood test during this phase.
A: Not necessarily. For women over 45 with typical symptoms, menopause can often be assessed based on clinical presentation and history alone. Blood tests can be helpful in certain circumstances, particularly when symptoms are atypical, when the diagnosis is uncertain, or when there are additional clinical questions to answer. We do not test for the sake of testing.
A: For most women without specific contraindications, and particularly when started close to the time of menopause, the evidence supports HRT as a safe and effective treatment for menopausal symptoms. Current guidance from bodies including the British Menopause Society and the Menopause Society supports HRT for eligible women, with the benefits generally outweighing the risks for symptomatic women in the early years of menopause. As with any treatment, decisions are individualised based on your medical history, risk factors, and personal preferences.
A: Standard HRT uses pharmaceutical-grade estrogen and progesterone formulations. Bioidentical HRT uses hormones whose molecular structure is identical to those produced naturally by the body. At Menovivre, we offer both approaches. The right choice depends on your individual clinical picture, preferences, and how your body responds. Our bioidentical HRT service offers a fully personalised protocol built around your hormonal profile.
A: HRT is not the only option. Non-hormonal approaches, including lifestyle intervention, nutritional medicine, sleep optimisation, targeted physical activity, and appropriate non-hormonal medications, can produce meaningful improvement in symptoms for many women. Vaginal and urinary symptoms can also be treated locally with options that have minimal or no systemic hormonal exposure. We will always discuss the full range of options with you.
A: For some women, symptoms improve over time. For others, particularly vasomotor symptoms, genitourinary changes, and the long-term risks to bone, cardiovascular, and metabolic health, they do not simply resolve without management. Active care during the menopausal transition meaningfully affects long-term health outcomes. We believe every woman deserves the opportunity to make informed decisions about that care.
A: Yes. Cardiovascular disease is the leading cause of death in women, and the risk rises during and after the menopausal transition. Estrogen plays a protective role in cardiovascular health, and its decline can affect cholesterol, blood pressure, and blood vessel function. This is one of the reasons we assess cardiovascular risk as part of every thorough menopause assessment, not as a separate concern.
